H2B1M_HUMAN - dbPTM
H2B1M_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID H2B1M_HUMAN
UniProt AC Q99879
Protein Name Histone H2B type 1-M
Gene Name HIST1H2BM
Organism Homo sapiens (Human).
Sequence Length 126
Subcellular Localization Nucleus. Chromosome.
Protein Description Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling..
Protein Sequence MPEPVKSAPVPKKGSKKAINKAQKKDGKKRKRSRKESYSVYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MPEPVKSAP
------CCCCCCCCC
55.38-
6N6-crotonyl-L-lysine--MPEPVKSAPVPKK
--CCCCCCCCCCCCC
52.17-
6Acetylation--MPEPVKSAPVPKK
--CCCCCCCCCCCCC
52.1719608861
6Butyrylation--MPEPVKSAPVPKK
--CCCCCCCCCCCCC
52.1727105113
6Crotonylation--MPEPVKSAPVPKK
--CCCCCCCCCCCCC
52.1721925322
6Lactoylation--MPEPVKSAPVPKK
--CCCCCCCCCCCCC
52.1731645732
6Lactylation--MPEPVKSAPVPKK
--CCCCCCCCCCCCC
52.1731645732
6Other--MPEPVKSAPVPKK
--CCCCCCCCCCCCC
52.1727105115
6Sumoylation--MPEPVKSAPVPKK
--CCCCCCCCCCCCC
52.1728112733
6Ubiquitination--MPEPVKSAPVPKK
--CCCCCCCCCCCCC
52.1723000965
7ADP-ribosylation-MPEPVKSAPVPKKG
-CCCCCCCCCCCCCC
37.7327723750
7Phosphorylation-MPEPVKSAPVPKKG
-CCCCCCCCCCCCCC
37.7323403867
12N6-crotonyl-L-lysineVKSAPVPKKGSKKAI
CCCCCCCCCCCHHHH
70.74-
12AcetylationVKSAPVPKKGSKKAI
CCCCCCCCCCCHHHH
70.7425825284
12CrotonylationVKSAPVPKKGSKKAI
CCCCCCCCCCCHHHH
70.7421925322
12LactoylationVKSAPVPKKGSKKAI
CCCCCCCCCCCHHHH
70.7431645732
12OtherVKSAPVPKKGSKKAI
CCCCCCCCCCCHHHH
70.7427105115
12UbiquitinationVKSAPVPKKGSKKAI
CCCCCCCCCCCHHHH
70.7423000965
13N6-crotonyl-L-lysineKSAPVPKKGSKKAIN
CCCCCCCCCCHHHHH
63.45-
13AcetylationKSAPVPKKGSKKAIN
CCCCCCCCCCHHHHH
63.4519608861
13CrotonylationKSAPVPKKGSKKAIN
CCCCCCCCCCHHHHH
63.4521925322
13OtherKSAPVPKKGSKKAIN
CCCCCCCCCCHHHHH
63.4524681537
15PhosphorylationAPVPKKGSKKAINKA
CCCCCCCCHHHHHHH
39.6012757711
16N6-crotonyl-L-lysinePVPKKGSKKAINKAQ
CCCCCCCHHHHHHHH
55.69-
16AcetylationPVPKKGSKKAINKAQ
CCCCCCCHHHHHHHH
55.6919608861
16CrotonylationPVPKKGSKKAINKAQ
CCCCCCCHHHHHHHH
55.6921925322
16LactoylationPVPKKGSKKAINKAQ
CCCCCCCHHHHHHHH
55.6931645732
17N6-crotonyl-L-lysineVPKKGSKKAINKAQK
CCCCCCHHHHHHHHH
57.08-
17AcetylationVPKKGSKKAINKAQK
CCCCCCHHHHHHHHH
57.0819608861
17CrotonylationVPKKGSKKAINKAQK
CCCCCCHHHHHHHHH
57.0821925322
17GlutarylationVPKKGSKKAINKAQK
CCCCCCHHHHHHHHH
57.0831542297
17LactoylationVPKKGSKKAINKAQK
CCCCCCHHHHHHHHH
57.0831645732
17OtherVPKKGSKKAINKAQK
CCCCCCHHHHHHHHH
57.0827105115
21N6-crotonyl-L-lysineGSKKAINKAQKKDGK
CCHHHHHHHHHHCCC
46.19-
21AcetylationGSKKAINKAQKKDGK
CCHHHHHHHHHHCCC
46.1919608861
21ButyrylationGSKKAINKAQKKDGK
CCHHHHHHHHHHCCC
46.1927105113
21CrotonylationGSKKAINKAQKKDGK
CCHHHHHHHHHHCCC
46.1921925322
21LactoylationGSKKAINKAQKKDGK
CCHHHHHHHHHHCCC
46.1931645732
21LactylationGSKKAINKAQKKDGK
CCHHHHHHHHHHCCC
46.1931645732
21OtherGSKKAINKAQKKDGK
CCHHHHHHHHHHCCC
46.1927105115
21UbiquitinationGSKKAINKAQKKDGK
CCHHHHHHHHHHCCC
46.1927667366
24N6-crotonyl-L-lysineKAINKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.66-
24AcetylationKAINKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.6619608861
24CrotonylationKAINKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.6621925322
24LactoylationKAINKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.6631645732
24OtherKAINKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.6624681537
25AcetylationAINKAQKKDGKKRKR
HHHHHHHHCCCCCCC
60.687493399
25OtherAINKAQKKDGKKRKR
HHHHHHHHCCCCCCC
60.6824681537
29UbiquitinationAQKKDGKKRKRSRKE
HHHHCCCCCCCCHHH
69.5423000965
31UbiquitinationKKDGKKRKRSRKESY
HHCCCCCCCCHHHHH
64.7023000965
33PhosphorylationDGKKRKRSRKESYSV
CCCCCCCCHHHHHHH
51.2228152594
35N6-crotonyl-L-lysineKKRKRSRKESYSVYV
CCCCCCHHHHHHHHH
52.86-
35AcetylationKKRKRSRKESYSVYV
CCCCCCHHHHHHHHH
52.8622389435
35CrotonylationKKRKRSRKESYSVYV
CCCCCCHHHHHHHHH
52.8621925322
35GlutarylationKKRKRSRKESYSVYV
CCCCCCHHHHHHHHH
52.8631542297
35OtherKKRKRSRKESYSVYV
CCCCCCHHHHHHHHH
52.8627105115
35SuccinylationKKRKRSRKESYSVYV
CCCCCCHHHHHHHHH
52.8622389435
35UbiquitinationKKRKRSRKESYSVYV
CCCCCCHHHHHHHHH
52.8623000965
37PhosphorylationRKRSRKESYSVYVYK
CCCCHHHHHHHHHHH
26.2423401153
38PhosphorylationKRSRKESYSVYVYKV
CCCHHHHHHHHHHHH
11.8421082442
39PhosphorylationRSRKESYSVYVYKVL
CCHHHHHHHHHHHHH
19.0925159151
41PhosphorylationRKESYSVYVYKVLKQ
HHHHHHHHHHHHHHH
7.6627155012
43PhosphorylationESYSVYVYKVLKQVH
HHHHHHHHHHHHHHC
4.2527273156
44AcetylationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9230779513
44GlutarylationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9231542297
44LactoylationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9231645732
44MethylationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.92-
44OtherSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9224681537
44UbiquitinationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9223000965
47AcetylationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.94185143
47GlutarylationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9431542297
47MethylationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.94-
47OtherVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9424681537
47SumoylationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.94-
47UbiquitinationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9427667366
53PhosphorylationLKQVHPDTGISSKAM
HHHHCCCCCCCHHHH
40.6530266825
56PhosphorylationVHPDTGISSKAMGIM
HCCCCCCCHHHHHHH
27.4223401153
57PhosphorylationHPDTGISSKAMGIMN
CCCCCCCHHHHHHHH
23.6330266825
58"N6,N6-dimethyllysine"PDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.29-
58AcetylationPDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.29163991
58MethylationPDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.29-
58OtherPDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.2924681537
58UbiquitinationPDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.2921906983
60SulfoxidationTGISSKAMGIMNSFV
CCCCHHHHHHHHHHH
4.2630846556
63SulfoxidationSSKAMGIMNSFVNDI
CHHHHHHHHHHHHHH
2.5930846556
65PhosphorylationKAMGIMNSFVNDIFE
HHHHHHHHHHHHHHH
17.1222617229
73MethylationFVNDIFERIAGEASR
HHHHHHHHHHHHHHH
17.20-
79PhosphorylationERIAGEASRLAHYNK
HHHHHHHHHHHHHCC
24.4322617229
80MethylationRIAGEASRLAHYNKR
HHHHHHHHHHHHCCC
42.83-
84PhosphorylationEASRLAHYNKRSTIT
HHHHHHHHCCCCCCC
19.4425884760
86"N6,N6,N6-trimethyllysine"SRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.33-
86AcetylationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.337681419
86LactoylationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.3331645732
86MethylationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.33-
86OtherSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.3327105115
86UbiquitinationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.3327667366
87MethylationRLAHYNKRSTITSRE
HHHHHCCCCCCCHHH
35.08-
88PhosphorylationLAHYNKRSTITSREI
HHHHCCCCCCCHHHH
26.2730266825
89PhosphorylationAHYNKRSTITSREIQ
HHHCCCCCCCHHHHH
32.1030266825
91PhosphorylationYNKRSTITSREIQTA
HCCCCCCCHHHHHHH
23.0930266825
92PhosphorylationNKRSTITSREIQTAV
CCCCCCCHHHHHHHH
24.8623401153
93MethylationKRSTITSREIQTAVR
CCCCCCHHHHHHHHH
36.07-
97PhosphorylationITSREIQTAVRLLLP
CCHHHHHHHHHHHCC
32.5523403867
100MethylationREIQTAVRLLLPGEL
HHHHHHHHHHCCHHH
19.70-
109SumoylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.73-
109AcetylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.73163955
109GlutarylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.7331542297
109LactoylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.7331645732
109MethylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.73-
109NeddylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.7332015554
109OtherLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.7324681537
109SumoylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.73-
109UbiquitinationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.7321906983
113O-linked_GlycosylationELAKHAVSEGTKAVT
HHHHHHHHHHHHHHH
30.96UniProtKB CARBOHYD
113PhosphorylationELAKHAVSEGTKAVT
HHHHHHHHHHHHHHH
30.9628176443
116PhosphorylationKHAVSEGTKAVTKYT
HHHHHHHHHHHHHHC
16.2720068231
117SumoylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.28-
117AcetylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2822389435
117GlutarylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2831542297
117LactoylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2831645732
117MalonylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2822389435
117MethylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.28-
117NeddylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2832015554
117OtherHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2827105115
117SuccinylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2822389435
117SumoylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2822389435
117UbiquitinationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2823000965
120PhosphorylationSEGTKAVTKYTSSK-
HHHHHHHHHHCCCC-
24.1620068231
121SumoylationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.67-
121AcetylationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.6722389435
121GlutarylationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.6731542297
121LactoylationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.6731645732
121NeddylationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.6732015554
121OtherEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.6727105115
121SuccinylationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.6722389435
121SumoylationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.6722389435
121UbiquitinationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.6722389435
122PhosphorylationGTKAVTKYTSSK---
HHHHHHHHCCCC---
11.50-
123PhosphorylationTKAVTKYTSSK----
HHHHHHHCCCC----
28.2524719451
124PhosphorylationKAVTKYTSSK-----
HHHHHHCCCC-----
32.8027251275
126AcetylationVTKYTSSK-------
HHHHCCCC-------
65.217431197
126NeddylationVTKYTSSK-------
HHHHCCCC-------
65.2132015554
126UbiquitinationVTKYTSSK-------
HHHHCCCC-------
65.2123000965

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
15SPhosphorylationKinaseMST1P26927
Uniprot
15SPhosphorylationKinaseSTK4Q13043
GPS
37SPhosphorylationKinaseAMPKQ9Y478
Uniprot
79SPhosphorylationKinaseAURKBQ96GD4
GPS
84YPhosphorylationKinaseAURKBQ96GD4
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
4KMethylation

24681537
4KMethylation

24681537
4Kubiquitylation

24681537
4Kubiquitylation

24681537
15SPhosphorylation

12757711
15SPhosphorylation

12757711
35KMethylation

21925322
35Kubiquitylation

21925322
37SPhosphorylation

12757711
79KMethylation

-
79KMethylation

-
79Kubiquitylation

-
79Kubiquitylation

-
113Subiquitylation

-
121Kubiquitylation

16307923
121Kubiquitylation

16307923
121KMethylation

16307923

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of H2B1M_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of H2B1M_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6; LYS-13; LYS-16; LYS-17;LYS-21 AND LYS-24, AND MASS SPECTROMETRY.
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-109, AND MASS SPECTROMETRY.
"Inhibition of core histones acetylation by carcinogenic nickel(II).";
Golebiowski F., Kasprzak K.S.;
Mol. Cell. Biochem. 279:133-139(2005).
Cited for: ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
Phosphorylation
ReferencePubMed
"Apoptotic phosphorylation of histone H2B is mediated by mammaliansterile twenty kinase.";
Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
Cell 113:507-517(2003).
Cited for: PHOSPHORYLATION AT SER-15.
Ubiquitylation
ReferencePubMed
"Histone H2B monoubiquitination functions cooperatively with FACT toregulate elongation by RNA polymerase II.";
Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A.,Reinberg D.;
Cell 125:703-717(2006).
Cited for: UBIQUITINATION AT LYS-121.
"Monoubiquitination of human histone H2B: the factors involved andtheir roles in HOX gene regulation.";
Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H.,Tempst P., Reinberg D.;
Mol. Cell 20:601-611(2005).
Cited for: UBIQUITINATION AT LYS-121.

TOP